World-Class Extractions Inc. (“World-Class” or the “Company”) (CSE:PUMP, FRA:WCF) is pleased to announce the signing of an agreement (the “Agreement”) with Nutralife Holdings, LLC (“Nutralife Holdings”) and Nutralife Extraction Limited Partnership (“Extraction LP”) to establish a joint venture (the “Joint Venture”) to develop, manage and operate a hemp extraction and processing facility in Imperial County, California (the “Facility”) to extract hemp oil from hemp biomass in compliance with the U.S. Agriculture Improvement Act of 2018 – also known as the Farm Bill.

Pursuant to the terms of the Joint Venture, the parties will enter into a definitive joint venture agreement (the “JV Agreement”) to extract hemp biomass into hemp oil, from which hemp oil products can be manufactured.  The parties intend to carry out the Joint Venture under a two-stage program.  Under Stage One, Nutralife Farming LP (“Farming LP”), an affiliate of Extraction LP, will enter into a 15 year lease agreement with the land owner, renewable for two additional 5 year terms, to lease up to 1,900 acres of farmland that are adjacent to the Facility (the “Property”), and Extraction LP will enter into a similar lease with the same land owner for the Facility (the “Leases”). Farming LP will obtain all necessary permits and licenses to carry out cultivation of hemp on the Property and will cultivate an initial crop of 80 acres of hemp, which World-Class will assist in drying and delivering to an extraction facility.  Following successful completion of Stage One, the parties intend to commence large-scale commercial production in Stage Two.  Word-Class will incorporate a wholly-owned subsidiary in the United States (“WCE-USA”), the Extraction LP will obtain all applicable regulatory approvals relating to the extraction of hemp at the Facility, and Farming LP will cultivate an initial crop of 400 acres of hemp, with a commitment to progressively cultivate up to 1,900 acres.  The Joint Venture will extract the hemp oil from hemp, and will be paid a processing fee equal to 1/3 of the fair market value of the extracted product.

Under the terms of the JV Agreement, the two parties will share economic benefits through a profit-sharing structure reflective of the respective interest of each party.  Holdings will own 60% of the Joint Venture and World-Class will own 40% of the Joint Venture.  The parties intend to extract hemp produced by the Farming LP in consideration for a processing fee of one-third of the value of the extracted product.  With a history rich in hemp-farming dating back to 1917, the climate and growing conditions in Imperial County, California are ideal, allowing for the site to grow at least two crops per year (where other states and counties grow one).  Based on two hemp harvests per year, the parties estimate that the Facility will accommodate the annual production of up to 3,800,000 kg of extracted biomass, which could yield between 225,000 kg to 350,000 kg of hemp oil distillate or hemp oil isolate.  Extraction services are expected to commence mid-2020.

Sample Economic Benefit Scenario – per Acre per Month Under Cultivation *

world class extractions

* Please note that all values above are expressed in USD, and are estimated amounts only and reflect forward-looking information, which means the estimates may change.  Please refer to “Cautionary Note Regarding Forward-Looking Statements” below.

Nutralife is an affiliate of Nutralife Wellness, LLC, (“Nutralife Wellness”) a leading manufacturer and vendor of hemp derived products, including face and body skincare, general wellness and products for pets (  Nutralife wellness has a team with over 30-years of combined experience in hemp derived products, manufacturing, branding and sales.  Nutralife Wellness currently sells its products in the USA and is targeting sales in foreign countries as laws permit.

Rosy Mondin, CEO of World-Class, stated, “Our Joint Venture with Nutralife marks a significant milestone for World-Class.  The deployment of our hemp extraction and processing facility in Southern California provides World-Class with access to the market in the United States.  The Joint Venture will not only extract and process hemp oil, but will also manufacture hemp derived products for human health and pet wellness with distribution of these products through Nutralife’s affiliate, Nutralife Wellness.  The Joint Venture will also allow us to offer our hemp extraction and processing services to licensed third-parties in the United States.”

Christopher Summers Managing Member of Nutralife stated, “World-Class represents the pinnacle of the hemp extraction and processing industry, having been proven in the more mature Canadian market.  We see this joint-venture as instrumental and foundational to our plant-to-product value chain strategy while expanding the World-Class footprint.  This will provide the Nutralife family of companies and others in the industry a local, trusted extraction and processing solution.”

About World-Class

World Class Extractions Inc. develops industrial grade extraction and processing systems for cannabis and hemp and is establishing extraction and processing facilities through strategic alliances and joint venture partnerships.  The vision of World-Class is to become an international leader in cannabis and hemp technology and processes to create some of the best high-margin, high-quality oils, premium refined oil-based products and premium consumer brands.  World-Class operates through two wholly owned subsidiaries: Soma Labs Scientific Ltd. and Greenmantle Products Ltd.

About Nutralife

Nutralife, LLC is an integrated family of companies focused on hemp cultivation, hemp extraction and production of hemp oil infused products for white label, private production and Nutralife’s retail brand.  As Nutralife strives to become the leading fully integrated hemp company the founding principles the company was built on remain true – innovation, quality and consistency, and will always be dedicated to ensuring that these principals remain uncompromised to provide the finest-quality, innovative, products possible for generations to come.  Nutralife has operations across Southern California with headquarters in San Diego and operates through three wholly owned subsidiaries: Nutralife Wellness, LLC, Nutralife Farms, LP and Nutralife Extractions, LP. (

Cautionary Note Regarding Forward-Looking Statements

Except for the statements of historical fact contained herein, the information presented in this news release constitutes “forward-looking statements” as such term is used in applicable United States and Canadian laws. These statements relate to analyses and other information that are based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management. Any other statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance (often, but not always, using words or phrases such as “expects” or “does not expect”, “is expected”, “anticipates” or “does not anticipate”, “plans, “estimates” or “intends”, or stating that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved) are not statements of historical fact and should be viewed as “forward-looking statements”. Forward-looking statements in this news release include statements regarding the Company’s intention to enter into the Joint Venture to outfit and operate the hemp-based oil extraction Facility, the expected benefits to the Company as a result of the proposed Joint Venture; the terms of the proposed Joint Venture Agreement; the effectiveness of the extraction technology; production estimates for the Farming LP’s cultivation operations; production estimates for WCE-USA’s extraction operations; Farming LP and Extraction LP successfully entering into the Leases on the terms indicated above or at all; Farming LP obtaining all necessary permits and licenses to carry out cultivation of hemp on the Property; the value expected to be generated by the sale of hemp oil distillate or isolate; and the estimated operating costs and expenses of the Joint Venture. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including that the Company may not open the hemp-based oil extraction Facility; the parties not being able to agree to terms of the Joint Venture Agreement; that the hemp-based oil extraction Facility may not be fully operation in mid-2020 if at all; that legislative changes may have an adverse effect on the Company’s business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; general business, economic, competitive, political and social uncertainties; failure to obtain any necessary approvals in connection with the proposed Joint Venture, including Farming LP failing to obtain the necessary permits and licenses to carry out cultivation of hemp on the Property; Farming LP and Extraction LP not entering into the Leases on the terms indicated above or at all; failure of Farming LP and Extraction LP to meet production estimates relating to cultivation and extraction, respectively; the value generated by the sale of hemp oil distillate or isolate being less than anticipated as a result of a decline in the prices of the foregoing; and the estimated operating costs and expenses being greater than those anticipated by the parties, and other factors beyond the Company’s control. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements contained in this news release and in any document referred to in this news release.

The Company assumes no obligation to update or supplement any forward-looking statements whether as a result of new information, future events or otherwise. This press release shall not constitute an offer to sell or the solicitation of an offer to buy securities.

Neither the CSE nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

Click here to connect with World Class Extractions Inc. (CSE:PUMP) for an Investor Presentation.



Cannabis - Will The Fortune 500 Join The Party?

Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
Cannabis Market Update: Q3 2020 in Review

Click here to read the previous cannabis update.

During the first few months of investment time in 2021, cannabis faced some volatility alongside optimism about federal changes in the most important market for the drug.

The cannabis business found its stride during Q1 thanks to policy change signals and consolidation.

To find out more, the Investing News Network (INN) asked experts about progress in the market during the first major period of the new year, and which developments investors should watch out for.


Cannabis - Will The Fortune 500 Join The Party?

Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!

Cannabis market update: New York and US potential boost operations

New York state’s legalization of recreational cannabis was a huge Q1 announcement that added pressure to the federal government when it comes to cannabis policy, said George Mancheril, co-founder and CEO of Bespoke Financial, a debt financing business with a particular focus on servicing cannabis businesses.

“It’s going to add to the chorus of voices in the federal scene to basically move sooner rather than later,” he explained to INN.

Following the US election in 2020, the momentum for cannabis businesses went on the upswing, as did company valuations, with the idea of expansion at the heart of it all, according to Mancheril.

Before starting Bespoke Financial, Mancheril learned from traditional investment banks, where he worked on lending, fixed income and debt markets with Goldman Sachs (NYSE:GS) and Guggenheim Partners.

Nawan Butt, portfolio manager with Purpose Investments, agrees with Mancheril. The financial expert told INN the ongoing legalization process seen in the US market is leading to expansion.

“It’s becoming more of a national move, then small pockets of proliferation. That’s very exciting about cannabis right now,” said Butt, who co-manages the Purpose Marijuana Opportunities Fund (NEO:MJJ).

This proliferation effect is causing a change in valuations and enthusiasm for US-based operations. Mancheril told INN that by the end of Q1, multi-state operators (MSOs) had raised approximately US$3.3 billion.

The cannabis lender said he sees the industry as having grown from the woes of 2019; it is now seeing a return to form by way of the excitement for an ongoing opening process in the US.

The expert explained that there is likely to be a windfall of capital in the wake of major federal changes for cannabis policy, although the timeline for these changes is becoming increasingly hard to predict.

Leading up to that capital influx, Mancheril said he wants to see operators really drill down on the value of desired assets and whether they make sense.


Cannabis - Will The Fortune 500 Join The Party?

Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!

“What I’d hope is that we continue to see bullish sentiment, but with some measure of responsibility, and let’s not just get over ahead of ourselves,” Mancheril told INN. “The idea is let’s minimize the volatility and continue growing responsibly.”

As far as struggles go, Butt explained that the cannabis industry has cemented itself as a growth-type sector, and as such there are macro environment pressures affecting the way these assets operate.

“We’ve seen this preference for cash flows at growth in the current or in the near future, rather than in the far future, and that’s what we’re seeing as far as valuations go in the broad market,” Butt said.

Cannabis market update: Volatility continues to rule as industry foundations build

Despite the industry’s current potential and the growing pains it has gone through as a whole in both the US and Canada, volatility remains a key factor in the cannabis investment scene.

Butt explained that the current shareholder base, which is dominated by hedge funds and retail investors, still lacks enough institutional support to avoid the day-to-day volatility cannabis has come to be known for.

These two investor groups, Butt said, can be easily spooked and excited by the news of the day when it comes to their investments.

“A lot of these institutions’ strategies are not about short-term profits, but they’re about long-term sustainability of the businesses themselves,” Butt said.

“That’s why you see a lot of volatility in the space, and that’s essentially what we’ve seen over the past, I’d say, three to two months as well,” he added.

That means investors shouldn’t expect an end to volatility anytime soon.

“It’s not about whether we continue to expect volatility, because we do,” Butt said. “We really think that the volatility will be taken out when the shareholder base becomes more institutional, but it’s really about understanding why there is volatility in the first place.”

Cannabis market update: Canadians talk up US business potential, but questions remain

A surge of mergers and acquisitions has taken over the Canadian cannabis sector recently as more producers see potential in America.

One of the biggest announcements in this regard came when Organigram Holdings (NASDAQ:OGI,TSX:OGI) secured a C$221 million investment deal from British American Tobacco (NYSE:BTI,LSE:BATS).

Using the funds, the two will work in tandem to develop new branded products designed to work on the international stage, including in the US. Organigram CEO Greg Engel previously told INN that the US represents a critical opportunity for Canadian companies, but the entry point isn’t as clean as it could be at the moment.


Cannabis - Will The Fortune 500 Join The Party?

Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!

While the long-term potential may be exciting for investors, Butt told INN he’s still unsure how the approach will work for Canadian companies.

The Purpose Investments expert said there will be plenty of space for the biggest Canadian names to pursue US market entries, beyond the initial hemp-derived CBD moves some operators have mde, since the US represents the biggest market in the world.

“But there’s just way too many unknowns right now to say exactly what that participation is going to look like, or when that participation will happen,” he said.

“What we do know is that currently the US MSOs are in a wonderful sort of position to expand on their market leadership that they have. And it will be tough for Canadians to come in and compete with them,” Butt said.

Canadian players still retain the upper hand at times in terms of valuation, which is confusing for both Butt and Dan Ahrens, chief operating officer and portfolio manager at AdvisorShares.

“The performance in quarterly earnings of US companies has been rather spectacular. They’ve knocked it out of the park in most instances,” Ahrens told INN.

Butt praised the recent performance reports from MSOs across the board, pointing to year-over-year growth lines and projections for continued positive performance.

In his view, share prices still don’t reflect company value. “Those are really being discounted at this point,” Butt told INN.

“We’ve seen the Canadian licensed producers be really hot stock performance-wise, outpacing the US (MSOs), and I’ll say it’s rather nonsensical to me,” said Ahrens, who oversees the AdvisorShares Pure Cannabis ETF (ARCA:YOLO) and the recently launched AdvisorShares Pure US Cannabis ETF (ARCA:MSOS).

Cannabis market update: Investor takeaway

The cannabis investment proposition finds itself at an interesting moment in time, as the entire sector eagerly awaits confirmation in the US at the federal level.

While for the Canadians waiting on the sidelines, this development may feel like a major necessity to address current financial struggles, for US-based operators, the heat around the corner could represent an increase to their already thriving operations.

Keep reading... Show less

 Trulieve Cannabis Corp. (“Trulieve” or the “Company”) (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States will release its first quarter 2021 financial results on Thursday, May 13, 2021 before markets open. Following the earnings release, management will host a conference call at 8:30 AM Eastern Time to review the financial results.

All interested parties can join the conference call by dialing 1-888-231-8191 or 1-647-427-7450, conference ID: 4880609. Please dial in 15 minutes prior to the call to secure a line. The conference call will be archived for replay until May 20, 2021 . To access the archived conference call, please dial 1-855-859-2056 and enter the encore code 4880609.

Keep reading... Show less

Appointment of Dr. Kelmendi, Assistant Professor of Psychiatry at Yale University and co-founder of the Yale Psychedelic Science Group, brings another experienced medical professional to Lobe’s advisory team.

 Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) is pleased to announce the appointment of Benjamin Kelmendi, MD, Assistant Professor of Psychiatry at Yale University School of Medicine, to its Scientific Advisory Board.

Keep reading... Show less

Ayurcann Holdings Corp. ( CSE: AYUR ) (the “ Company ” or ” Ayurcann “), a Canadian extraction company specializing in the processing of cannabis and hemp for the production of oils and various derivative products, is pleased to unveil further details of its Phase 2 expansion plans.

Ayurcann has commenced trading on the Canadian Securities Exchange (” CSE “) on April 8, 2021 and subsequently announced a private placement of up to $500,000 (” Financing “), as per the Company’s press release dated April 12, 2021. The proceeds of the Financing are intended to be used to further pursue Phase 2 of the expansion of the production capacity of the Company’s Pickering facility.

Keep reading... Show less